This report was first published by Endpoints News. To see the original version, click here
Researchers led by Broad Institute gene editing star David Liu have come up with a new use for prime editing that can tackle a bucket of diseases with the same root cause, which they say opens up a more straightforward path to address dozens or even hundreds of genetic diseases.
The ambitious idea could, in theory, offer sweeping ways to treat genetic diseases like cystic fibrosis, Tay-Sachs, and many very rare diseases that shorten lives and that, if they have treatments at all, currently rely on complicated or costly therapies unique to each ailment.
您已阅读8%（647字），剩余92%（7325字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。